BiWaze® Clear

BiWaze® Clear

BiWaze® Clear

Product catalog summary
Overview of BiWaze Clear System
The BiWaze Clear System provides oscillating lung expansion (OLE) therapy to treat and prevent atelectasis, remove retained lung secretions, and reduce the work of breathing. It combines airway clearance therapies, including lung expansion, high-frequency oscillation, and nebulization, to clear airways and thin mucus in just 10 minutes.
Key Features
  • Closed circuit design with Aerogen® Solo nebulizer
  • Dual air-path control for separate inhaled and exhaled air
  • Stores up to 10 therapy profiles
  • Advanced therapy programming for customization
  • Touchscreen control
  • Lightweight (9 lbs) with lithium-ion battery
Applications in Healthcare
The system is used in hospitals and post-acute care settings to reduce postoperative pulmonary complications (PPCs), particularly in high-risk patients. Research indicates a significant reduction in PPCs and length of hospital stay.
Target Patient Population
BiWaze Clear is suitable for both pediatric and adult patients across various departments, including emergency, trauma, surgery, and intensive care units. It addresses conditions such as pneumonia, trauma, burns, stroke, hypoventilation, mucus plugging, and postoperative complications.
Clinical Efficacy
Studies show a 31% reduction in PPCs for all patients and a 45% reduction for patients with ASA classifications 4/5. Additionally, there is a reduction in ICU and hospital days.
Contact Information
For more details, visit the ABMRC website or contact customer support at 1-877-ABM-RC01.
See more

Catalog excerpts

BiWaze® Clear-1

For Hospital and Post-Acute Care How does the BiWaze Clear System work? BiWaze® Clear System provides oscillating lung expansion (OLE) therapy to help treat and prevent atelectasis, remove retained secretions from deep in the lungs and reduce work of breathing. BiWaze Clear expands and clears the airways through a combination of airway clearance therapies in just 10 minutes. Alternating therapies of lung expansion and high frequency oscillation combined with nebulization helps calm inflamed airways and thin mucus. C losed circuit design with an Aerogen® Solo nebulier D ual air-path control to seperate inhaled and exhaled air S tored therapy profiles (up to 10) A dvance therapy programming to customize each therapy phase T ouchscreen control L ight weight system (9 lbs) I ncludes a lithium-ion battery wit

 Open the catalog to page 1
BiWaze® Clear-2

Research shows that OLE therapy reduced the rate of postoperative pulmonary complications (PPCs) in high-risk patients as classified by the American Society of Anesthesiologists (ASA). PPCs may result in morbidity, mortality and healthcare expenditures.1 BiWaze Clear can be used throughout the continuum of care, hospital to home for pediatric and adult patients. REDUCTION IN POSTOPERATIVE PULMONARY COMPLICATIONS REDUCTION IN LENGTH OF STAY Huynh TT, Liesching TN, Cereda M, Lei Y, Frazer MJ, Nahouraii MR, Diette GB. Efficacy of Oscillation and Lung Expansion in Reducing Postoperative Pulmonary...

 Open the catalog to page 2

All ABM Respiratory Care catalogs and technical brochures

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.